Hypoxia and Medicine

Home > Ischemia Information > Ischemia News

Ischemia News

  • Series of articles explore recent evidence-based vascular medicine Wednesday, July 20, 2011 @ 2:40AMAs the population ages and obesity and diabetes increase, more people suffer from noncardiac vascular diseases. In the July/August issue of Progress in Cardiovascular Diseases, published by Elsevier, a series of articles from recognized experts on key topics in vascular disease and endovascular medicine provide an insightful compendium of the evidence available to help improve the care of this ...
  • International Academy of Cardiology Announces 16th World Congress on Heart Disease Annual Scientific Sessions July 23 ... Tuesday, July 19, 2011 @ 10:48PMOne of the world's most prestigious scientific events will take place in Vancouver BC, Canada, July 23-26, 2011 as preeminent cardiologists arrive for the International Academy of Cardiology, 16th World Congress on Heart Disease, Annual Scientific Sessions 2011. Five hundred and thirty-nine scientific papers have been selected for presentation from forty-eight countries. Dr. Jay L. Mehta, M.D ...
  • Cell Regeneration: A Look at Bioheart BHRT and Aastrom ASTM Monday, July 18, 2011 @ 2:13PMCell regeneration has been long-heralded as holding a great potential for revolutionizing the future of care for countless ailments and diseases. The wheels of biotechnology turn notoriously slow and cell regeneration therapies are now beginning to reach advanced stages.Bioheart, Inc. OTCBB: BHRT offers a diversified package of cardiac repair systems and is moving deep into clinical trials ...
  • OrbusNeich's Genous(TM) Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk ... Monday, July 18, 2011 @ 1:10PMHONG KONG, July 18, 2011 /PRNewswire/ -- Data from high-risk patients requiring early discontinuation of dual antiplatelet therapy (DAPT) due to nondeferrable, non-cardiac surgery show good short- and long-term clinical and safety outcomes following treatment with OrbusNeich's Genous Stent, according to a study published online on the journal Minerva Cardioangiologica 's website. In the single ...
  • Too tough to go see a doctor Sunday, July 17, 2011 @ 11:43PMMen die younger than women, according to the World Health Organisation. Men live up to an average age of 71, compared to women who can live up to 76 years.
  • Loh: Huge questions in coronary care Saturday, July 16, 2011 @ 3:53PMIn a July article published in the Journal of the American Medical Association , an American College of Cardiology initiative called the National Cardiovascular Data Registry examined the appropriateness of coronary angioplasty and stenting.
  • Fundraiser to benefit Mission Viejo boy with brain condition Friday, July 15, 2011 @ 7:41PMA fundraiser will be held Sunday at several area Wahoo's restaurants to benefit Michael Young, a 7-year-old Mission Viejo boy, who needs treatments for brain ischemia, a condition that disallows adequate blood flow to the sensory area of his brain....
  • St. Jude Medical's Novel Heart Disease Diagnostic Tool Cleared in Europe Friday, July 15, 2011 @ 8:50AMSt. Jude has an inventive new heart disease treatment.
  • FDA ODAC recommends approval of Seattle Genetics' ADCETRIS for Hodgkin lymphoma after ASCT Friday, July 15, 2011 @ 8:45AMSeattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
  • OCT firm Michelson Diagnostics sets up US subsidiary Friday, July 15, 2011 @ 6:28AMUK-based imaging company specializes in optical coherence tomography (OCT) equipment currently in clinical trials in the US.
  • St. Jude Medical’s novel heart disease diagnostic tool cleared in Europe Thursday, July 14, 2011 @ 11:57AMSt. Jude Medical (NYSE:STJ) announced Thursday that it has received European regulatory clearance for its Ilumien system, a diagnostic tool for treating heart disease. The Minnesota maker of new innovative medical devices said the system is the world’s first and only diagnostic tool that integrates optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on [...]
  • European Intravascular Ultrasound Catheter and Pressure Guidewire Market to Grow at Nine Percent Per Year Through 2015 Thursday, July 14, 2011 @ 7:10AMTORONTO--(BUSINESS WIRE)--The results of the recent FAME clinical trial have led the European Society of Cardiology (ESC) to list FFR guidewires, as a Class 1A recommendation, the highest available.
  • St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System Thursday, July 14, 2011 @ 7:09AMST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has received European CE Mark approval for its ILUMIEN™ system, the first integrated diagnostic technology that combines optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on one platform. The combined system offers physicians advanced ...
  • OPK Biotech LLC – Regulatory Milestone Reached Thursday, July 14, 2011 @ 5:07AMHemopure Now Approved in Russia (PRWeb July 14, 2011) Read the full story at http://www.prweb.com/releases/2011/7/prweb8630451.htm
  • Stem-Cell Stocks May Now Be Worth The Risk Wednesday, July 13, 2011 @ 2:58PMStem-Cell Stocks May Now Be Worth The Risk
  • Study evaluates eye findings after use of intra-arterial chemotherapy for retinoblastoma Tuesday, July 12, 2011 @ 7:25PMIn a study examining eight eyes that were removed following intra-arterial chemotherapy (IAC) for treatment of retinoblastoma (a tumor of the retina of the eye), there was variable response of the tumor to therapy but also evidence of ocular complications.
  • Intra-Arterial Chemotherapy For Retinoblastoma Must Be Used With Caution Tuesday, July 12, 2011 @ 3:24PMAccording to a study report published online by Archives of Ophthalmology, one of the JAMA/Archives journals, eight eyes with retinoblastoma (a tumor of the retina of the eye) that were treated by intra-arterial chemotherapy (IAC), post-removal, showed evidence of ocular complications and variable response of the tumor to the treatment. Intra-arterial chemotherapy (IAC) is a novel but ...
  • Cytori Completes Equity Agreement; Funding to Support ADVANCE Clinical Trial & Other Corporate Initiatives Tuesday, July 12, 2011 @ 8:52AMSAN DIEGO, CA--(Marketwire - Jul 12, 2011) - Cytori Therapeutics ( NASDAQ : CYTX ) entered into an equity purchase agreement with Seaside 88, LP ('Seaside'). As part of the agreement, Seaside completed the purchase of 1,326,262 common shares of Cytori at $4.52 per share for gross proceeds of $6,000,000 and committed to purchase an additional 5,000,000 shares of common shares over a nine month ...
  • Massachusetts Firm Selected to Build Medical Implant Device Tuesday, July 12, 2011 @ 6:12AMLitron Inc. of Agawam MA has been selected by Angel Medical Systems, Inc. of Shrewsbury NJ to build the Phase II implants for their Guardian Implantable Device. (PRWeb July 12, 2011) Read the full story at http://www.prweb.com/releases/2011/7/prweb8634188.htm
  • JCI Online Early Table Of Contents: July 11, 2011 Monday, July 11, 2011 @ 10:12PMEDITOR'S PICK: Do-it-yourself brain repair following stroke Stroke is a leading cause of long-term disability and death in the United States. A team of researchers — led by Gregory Bix, at Texas A&M College of Medicine, College Station — has identified a way to exploit one of the brain's self-repair mechanisms to protect nerve cells and enhance brain repair in rodent models of stroke. The ...
  • Women should encourage the men in their lives to get regular medical examinations Monday, July 11, 2011 @ 7:33PMMEN die younger than women, according to the World Health Organisation. Men live up to an average age of 71, compared to women who can live up to 76 years.
  • OAT Trial Had Little Impact on Clinical Practice Monday, July 11, 2011 @ 3:18PMOnce again a study finds that cardiologists don?t always pay attention to the literature and g
  • JCI online early table of contents: July 11, 2011 Monday, July 11, 2011 @ 11:14AM( Journal of Clinical Investigation ) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, July 11, 2011, in the JCI: Do-it-yourself brain repair following stroke; PXR: a stepping stone from environmental chemical to cancer?; Sex hormone protection from type 2 diabetes; A Rock(in') target for treating breast cancer ...
  • Scientists study neuronal excitation to treat neurological disorders Monday, July 11, 2011 @ 8:03AMOh, the challenges of being a neuron, responsible for essential things like muscle contraction, gland secretion and sensitivity to touch, sound and light, yet constantly bombarded with signals from here, there and everywhere.
  • Morning Heart Attacks Cause More Damage, Study Finds Monday, July 11, 2011 @ 6:30AMWEDNESDAY, April 27 (HealthDay News) -- If you suffer a heart attack in the morning, it is likely to be more severe than having one at any other time of day, a Spanish research team reports.
  • Quality of Care After Joint Surgery May Affect Heart Health Monday, July 11, 2011 @ 4:36AMFRIDAY, Aug. 27 (HealthDay News) -- The quality of care a patient receives immediately after orthopedic surgery has a major impact on long-term heart health, a new study shows.
  • OPK Biotech LLC Putting Down Roots and Growing Sunday, July 10, 2011 @ 2:15AMThe Company has grown from 8 to over 100 employees since commencement of operations in 2009. (PRWeb July 10, 2011) Read the full story at http://www.prweb.com/releases/2011/7/prweb8630492.htm
  • Adult Stem Cells May Improve Cardiac Function In Angina Patients Friday, July 8, 2011 @ 2:56PMStudy finds improvement in chest pain and exercise tolerance New research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options). The phase II ...
  • Medistem Inc Together With Argentinean Ministry of Health Laboratory (CUCAIBA) Publish Scientific Report on Use of ... Friday, July 8, 2011 @ 1:36PMPaper Provides Rationale for Expanded Use of Mesenchymal Stem Cells Such as ERC
  • History of cancer increases risk for developing blood clotting issues following knee arthroscopy Friday, July 8, 2011 @ 10:33AMA history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota analyzed the records of more than 12,000 patients who had undergone the common knee procedure.
  • Northwestern-Baxter Heart Stem Cell Study Shows Progress Friday, July 8, 2011 @ 8:38AMCHICAGO (Chicago Tribune) -- A treatment that uses adult stem cells to rebuild failing hearts reduced severe chest discomfort, known as angina, in patients and improved their tolerance for exercise a year after injection, according to a study led by a Northwestern University researcher working with Baxter International Inc.
  • Adult stem cells may improve cardiac function in angina patients; Study finds improvement in chest pain and exercise ... Friday, July 8, 2011 @ 7:10AMA new Phase II study found injections of adult patients' own stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina.
  • Jab of own stem cells may help treat cardiac function in angina patients Friday, July 8, 2011 @ 6:34AMWashington, July 08 (ANI): A new research has found that injections of adult patients' own stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options).
  • Mesenchymal stem cells protect and heal Friday, July 8, 2011 @ 3:48AMA stem cell that can morph into a number of different tissues is proving a natural protector, healer and antibiotic maker, researchers at Case Western Reserve University and their peers have found.
  • Autologous adult stem cells reduce frequency of angina episodes Friday, July 8, 2011 @ 3:48AMNew research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options).
  • Stem-cell heart study shows promise on angina Friday, July 8, 2011 @ 2:02AMCHICAGO -- A treatment that uses adult stem cells to rebuild failing hearts reduced severe chest discomfort, known as angina, in patients and improved their tolerance for exercise a year after injection, according to a study led by a Northwestern University researcher working with Baxter International Inc.
  • Study uses stem cells to repair hearts Thursday, July 7, 2011 @ 4:30PMA treatment that uses adult stem cells to rebuild failing hearts reduced severe chest discomfort, known as angina, in patients and improved their tolerance for exercise a year after injection, a study of research from a Northwestern University doctor shows.
  • NU-Baxter study uses stem cells to repair hearts Thursday, July 7, 2011 @ 3:39PMA treatment that uses adult stem cells to rebuild failing hearts reduced severe chest discomfort, a study published Thursday shows.
  • Phase Two Study Suggests Use of Adult Autologous Stem Cells May Improve Cardiac Function in Angina Patients Thursday, July 7, 2011 @ 3:26PMNew research published online today in Circulation Research found that injections of adult patients own CD34+ stem cells reduced reports of ...
  • donga.com[English donga] Wednesday, July 6, 2011 @ 6:03PMThe state-run Rural Development Administration said Wednesday that it has produced a genetically engineered pig whose organs will cause less rejection when transplanted into humans.
  • Appropriateness of Percutaneous Coronary Intervention [Original Contribution] Tuesday, July 5, 2011 @ 3:49PMContext Despite the widespread use of percutaneous coronary intervention (PCI), the appropriateness of these procedures in contemporary practice is unknown. Objective To assess the appropriateness of PCI in the United States. Design, Setting, and Patients Multicenter, prospective study of patients within the National Cardiovascular Data Registry undergoing PCI between July 1, 2009, and September ...
  • NCDR Study in JAMA: Only Half of Nonacute PCIs Deemed Appropriate Tuesday, July 5, 2011 @ 3:01PMNearly half of all PCIs performed for nonacute cases may be inappropriate, according to a report from the National Cardiovascular Data Registry published in JAMA. Paul Chan and colleagues analyzed data from more than half a million PCI procedures performed between July 1, 2009 and September 30, 2010.Out of 500,154 PCIs they found that:--355,417 (71.1%) were for acute indications.STEMI: 103,245 ...
  • Chantix Linked to Heart Problems Tuesday, July 5, 2011 @ 12:08PMThe Canadian Medical Association Journal has issued a report suggesting that Pfizer’s smoking cessation drug varenicline, which is sold under the brand name Chantix, is associated with a 72-percent higher adverse cardiovascular events than the placebo. The analysis of data was drawn from 14 clinical trials of more than 8,000 participants. Thirteen of the trials excluded people with a history of ...
  • Pace Technology Research Conducted at Cleveland Clinic Presented at the 2011 World Congress of Microsurgery Tuesday, July 5, 2011 @ 7:10AMALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV) (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced the presentation of preclinical research conducted by Maria Siemionow, MD, PhD, DSc, at ...
  • Makarenko, Shepitko released from custody Tuesday, July 5, 2011 @ 7:02AMKyiv Court of Appeals has released former head of the State Customs Service Anatoliy Makarenko and former Deputy Head of the Energy Regional Customs Service Taras Shepitko from custody.
  • 'Future of regenerative medicine is stem cell research' Sunday, July 3, 2011 @ 12:59AMMumbai, July 2 : Unistem Biosciences,a holistic stem cell company, announced its participation in the India stem cell conclave & exhibition 2011 to be held in Mumbai on July 2-3. Unsitem Biociences will be presenting current validated research on stem cell therapy at the conclave.
  • Research and Markets: The Stem Cell Market Outlook Friday, July 1, 2011 @ 7:48AMDUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b79257/the_stem_cell_mark) has announced the addition of the "The Stem Cell Market Outlook" report to their offering. This report covers the commercialization of stem cells (primarily derived from adult tissues) which are transplanted into patients to improve the function of ...
  • Lantheus commences flurpiridaz F 18 PET MPI Phase 3 clinical trial for detection of coronary artery disease Friday, July 1, 2011 @ 3:50AMLantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of the first of two Phase 3 clinical trials to assess myocardial perfusion using Positron Emission Tomography (PET) imaging with flurpiridaz F 18 in patients with suspected or known coronary artery disease (CAD).
  • Take Heart: Get Scanned, Save an Athlete Friday, July 1, 2011 @ 12:03AMDomHeart21 Foundation Continues Mission for SCA Awareness Some young athletes are more apt to die than others. Some local residents want to promote awareness of sudden cardiac arrest among our athletes. Farmingdale’s chapter of the Rotary Club met at Bollinger’s restaurant last month to discuss emerging medical technology that assesses heart function. Multifunction cardiogram is a cardiac ...
  • Medistem Licensee RenovoCyte LLC Receives FDA INAD for Universal Donor Endometrial Regenerative Cells (ERC) Thursday, June 30, 2011 @ 10:39PMApproval Allows for Initiation of Pilot Studies in Horses, Cats, Dogs and Rabbits